New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 20, 2014
17:04 EDTUTHR, SUPNSupernus receives $2M milestone payment for launch of Orenitram
Supernus Pharmaceuticals (SUPN) announced that United Therapeutics Corporation (UTHR) has paid Supernus a $2M milestone payment under United Therapeutics' license agreement with Supernus. This payment was due upon the launch of Orenitram Extended-Release Tablets for the treatment of pulmonary arterial hypertension, in the United States. Orenitram utilizes a Supernus patented technology platform. In addition to the launch milestone, Supernus will receive royalties on net sales of Orenitram, and may become entitled to additional milestone payments.
News For SUPN;UTHR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 4, 2015
12:32 EDTUTHRUnited Therapeutics downgraded to Hold from Buy at Standpoint Research
Subscribe for More Information
March 2, 2015
07:20 EDTUTHRCowen to hold a conference
Subscribe for More Information
February 24, 2015
06:19 EDTUTHRUnited Therapeutics reports Q4 Remodulin sales $136.59M
Subscribe for More Information
06:19 EDTUTHRUnited Therapeutics reports Q4 non-GAAP EPS $3.21, consensus $2.03
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use